L-2-Hydroxyglutarate production arises from noncanonical enzyme function at acidic pH. Academic Article uri icon

Overview

abstract

  • The metabolite 2-hydroxyglutarate (2HG) can be produced as either a D-R- or L-S- enantiomer, each of which inhibits α-ketoglutarate (αKG)-dependent enzymes involved in diverse biologic processes. Oncogenic mutations in isocitrate dehydrogenase (IDH) produce D-2HG, which causes a pathologic blockade in cell differentiation. On the other hand, oxygen limitation leads to accumulation of L-2HG, which can facilitate physiologic adaptation to hypoxic stress in both normal and malignant cells. Here we demonstrate that purified lactate dehydrogenase (LDH) and malate dehydrogenase (MDH) catalyze stereospecific production of L-2HG via 'promiscuous' reduction of the alternative substrate αKG. Acidic pH enhances production of L-2HG by promoting a protonated form of αKG that binds to a key residue in the substrate-binding pocket of LDHA. Acid-enhanced production of L-2HG leads to stabilization of hypoxia-inducible factor 1 alpha (HIF-1α) in normoxia. These findings offer insights into mechanisms whereby microenvironmental factors influence production of metabolites that alter cell fate and function.

authors

  • Intlekofer, Andrew Michael
  • Wang, Bo
  • Liu, Hui
  • Shah, Hardik
  • Carmona-Fontaine, Carlos
  • Rustenburg, Ariën S
  • Salah, Salah
  • Gunner, M R
  • Chodera, John D
  • Cross, Justin R
  • Thompson, Craig B

publication date

  • March 6, 2017

Research

keywords

  • Biocatalysis
  • Glutarates
  • L-Lactate Dehydrogenase
  • Malate Dehydrogenase

Identity

PubMed Central ID

  • PMC5516644

Scopus Document Identifier

  • 85014514282

Digital Object Identifier (DOI)

  • 10.1038/nchembio.2307

PubMed ID

  • 28263965

Additional Document Info

volume

  • 13

issue

  • 5